🚀 VC round data is live in beta, check it out!
Jiangsu Wuzhong Pharmaceutical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Jiangsu Wuzhong Pharmaceutical and similar public comparables like Pluri, BioXcel Therapeutics, Advicenne, INmune Bio and more.
Jiangsu Wuzhong Pharmaceutical Overview
About Jiangsu Wuzhong Pharmaceutical
Jiangsu Wuzhong Pharmaceutical Development Co Ltd is a China-based company. It develops, produces and sells medicines while engages in real estate development.
Founded
1994
HQ
Employees
2.6K
Website
Sectors
Financials (FY)
EV
$246M
Jiangsu Wuzhong Pharmaceutical Stock Performance
Jiangsu Wuzhong Pharmaceutical has current market cap of $35M, and enterprise value of $246M.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $246M | $35M | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJiangsu Wuzhong Pharmaceutical Valuation Multiples
Jiangsu Wuzhong Pharmaceutical Financial Valuation Multiples
As of March 11, 2026, Jiangsu Wuzhong Pharmaceutical has market cap of $35M and EV of $246M.
Equity research analysts estimate Jiangsu Wuzhong Pharmaceutical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $35M | XXX | $35M | XXX | XXX | XXX |
| EV (current) | $246M | XXX | $246M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Jiangsu Wuzhong Pharmaceutical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Jiangsu Wuzhong Pharmaceutical Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pluri | XXX | XXX | XXX | XXX | XXX | XXX |
| BioXcel Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Advicenne | XXX | XXX | XXX | XXX | XXX | XXX |
| INmune Bio | XXX | XXX | XXX | XXX | XXX | XXX |
| Generation Bio | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Jiangsu Wuzhong Pharmaceutical M&A Activity
Jiangsu Wuzhong Pharmaceutical acquired XXX companies to date.
Last acquisition by Jiangsu Wuzhong Pharmaceutical was on XXXXXXXX, XXXXX. Jiangsu Wuzhong Pharmaceutical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Jiangsu Wuzhong Pharmaceutical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialJiangsu Wuzhong Pharmaceutical Investment Activity
Jiangsu Wuzhong Pharmaceutical invested in XXX companies to date.
Jiangsu Wuzhong Pharmaceutical made its latest investment on XXXXXXXX, XXXXX. Jiangsu Wuzhong Pharmaceutical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Jiangsu Wuzhong Pharmaceutical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Jiangsu Wuzhong Pharmaceutical
| When was Jiangsu Wuzhong Pharmaceutical founded? | Jiangsu Wuzhong Pharmaceutical was founded in 1994. |
| Where is Jiangsu Wuzhong Pharmaceutical headquartered? | Jiangsu Wuzhong Pharmaceutical is headquartered in China. |
| How many employees does Jiangsu Wuzhong Pharmaceutical have? | As of today, Jiangsu Wuzhong Pharmaceutical has over 2K employees. |
| Is Jiangsu Wuzhong Pharmaceutical publicly listed? | Yes, Jiangsu Wuzhong Pharmaceutical is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Jiangsu Wuzhong Pharmaceutical? | Jiangsu Wuzhong Pharmaceutical trades under 600200 ticker. |
| When did Jiangsu Wuzhong Pharmaceutical go public? | Jiangsu Wuzhong Pharmaceutical went public in 1999. |
| Who are competitors of Jiangsu Wuzhong Pharmaceutical? | Jiangsu Wuzhong Pharmaceutical main competitors are Pluri, BioXcel Therapeutics, Advicenne, INmune Bio. |
| What is the current market cap of Jiangsu Wuzhong Pharmaceutical? | Jiangsu Wuzhong Pharmaceutical's current market cap is $35M. |
| Is Jiangsu Wuzhong Pharmaceutical profitable? | No, Jiangsu Wuzhong Pharmaceutical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.